Post-translational processing of insulin-like growth factors

Hormone and Metabolic Research

Volumn 31, Issue 2-3, 1999, Pages 43-49

  Duguay, S J ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Shire Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; SOMATOMEDIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; MOLECULAR WEIGHT; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PROCESSING; PROTEIN SYNTHESIS; REGULATORY MECHANISM;

EID: 0032952169     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978697     Document Type: Article

References (63)

1. 1. Steiner DF, Oyer PE. The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci (USA) 1967; 57: 473-80
2. 2. Steiner DF, Cunningham D, Spigelman L, Aten B. Insulin biosynthesis: Evidence for a precursor. Science 1967; 157: 697-700
3. 3. Rouille Y, Duguay SJ, Lund K, Furuta M, Gong Q, Lipkind G, Oliva Jr AA, Chan SJ, Steiner DF. Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: The subtilisin-like proprotein convertases. Frontiers in Neuroendocrinology 1995; 16: 322-61
4. 4. Daughaday WH, Rotwein P. Insulin-like growth factors I and II: Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989; 10: 68-91
5. 5. Chew SL, Lavender P, Clark AJL, Ross RJM. An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology 1995; 136: 1939-44
6. 6. Lund PK. Insulin-like growth factor I: molecular biology and relevance to tissue-specific expression and action. Recent Prog Horm Res 1994; 49: 125-48
7. 7. Duguay SJ, Park LK, Samadpour M, Dickhoff WW. Nucleotide sequence and tissue distribution of three insulin-like growth factor I prohormones in salmon. Mol Endocrinol 1992; 6: 1201-10
8. 8. Duguay SJ, Swanson P, Dickhoff WW. Differential expression and hormonal regulation of alternatively spliced IGF-I mRNA transcripts in salmon. J Mol Endocrinol 1994; 12: 25-37
9. 9. Lowe Jr WL, Lasky SR, LeRoith D, Roberts Jr CT. Distribution and regulation of rat insulin-like growth factor-I messenger ribonucleic acids encoding alternative carboxyterminal E-peptides: evidence for differential processing and regulation in liver. Mol Endocrinol 1988; 2: 528-35
10. 10. Schmidt WK, Moore H-PH. Synthesis and targeting of insulin-like growth factor-I to the hormone storage granules in an endocrine cell line. J Biol Chem 1994; 269: 27115-24
11. 11. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem 1978; 253: 2769-76
12. 12. Duguay SJ, Lai-Zhang J, Steiner DF. Mutational analysis of the insulin-like growth factor I prohormone processing site. J Biol Chem 1995; 270: 17566-74
13. 13. Halban PA, Irminger J-C. Sorting and processing of secretory proteins. Biochem J 1994; 299: 1-18
14. 14. Duguay SJ, Milewski WM, Young BD, Nakayama K, Steiner DF. Processing of wild-type and mutant proinsulin-like growth factor-IA by subtilisin-related proprotein convertases. J Biol Chem 1997; 272: 6663-70
15. 15. Bovenberg WA, Dauwerse JG, Pospiech HM, Van Buul-Offers SC, Van den Brande JL, Sussenbach JS. Expression of recombinant human insulin-like growth factor I in mammalian cells. Mol Cell Endocrinol 1990; 74: 45-59
16. 16. Conover CA, Baker BK, Hintz RL. Cultured human fibroblasts secrete insulin-like growth factor IA prohormone. J Clin Endo Metab 1989; 69: 25-30
17. 17. Conover CA, Baker BK, Bale LK, Clarkson JT, Liu F, Hintz RL. Human hepatoma cells synthesize and secrete insulin-like growth factor Ia prohormone under growth hormone control. Reg Pept 1993; 48: 1-8
18. 18. Nakanishi Y, Mulshine JL, Kasprzyk PG, Natale RB, Maneckjee R, Avis I, Treston AM, Gazdar AF, Minna JD, Cuttitta F. Insulin-like growth factor I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro. J Clin Invest 1988; 82: 354-9
19. 19. Sara VR, Carlsson-Skwirut C, Andersson C, Hall E, Sjogren B, Holmgren A, Jornvall H. Characterization of somatomedins from human fetal brain: Identification of a variant form of insulin-like growth factor I. Proc Natl Acad Sci (USA) 1986; 83: 4904-7
20. 20. Carlsson-Skwirut C, Jornvall H, Holmgren A, Andersson C, Bergman T, Lundquist G, Sjogren B, Sara VR. Isolation and characterization of variant IGF-1 as well as IGF-2 from adult human brain. FEBS Lett 1986; 201: 46-50
21. 21. Francis GL, Read LC, Ballard FJ, Bagley CJ, Upton FM, Cravestock PM, Wallace JC. Purification and partial sequence analysis of insulin-like growth factor-1 from bovine colostrum. Biochem J 1986; 233: 207-13
22. 22. Francis GL, Upton FM, Ballard FJ, McNeil KA, Wallace JC. Insulin-like growth factors 1 and 2 in bovine colostrum. Biochem J 1988; 251: 95-103
23. 23. Ogasawara M, Karey KP, Marquardt H, Sirbasku DA. Identification and purification of truncated insulin-like growth factor 1 from porcine uterus: Evidence for a high biological potency. Biochemistry 1989; 28: 2710-21
24. 24. Yamamoto H, Murphy LJ. Generation of des-(1-3) insulin-like growth factor-I in serum by an acid protease. Endocrinology 1994; 135: 2431-9
25. 25. Bach MA, Roberts Jr CT, Smith EP, LeRoith D. Alternative splicing produces messenger RNAs encoding insulin-like growth factor-I prohormones that are differentially glycosylated in vitro. Mol Endocrinol 1990; 4: 899-904
26. 26. Simmons JG, Van Wyk JJ, Hoyt EC, Lund PK. Multiple transcription start sites in the rat insulin-like growth factor-I gene give rise to IGF-I mRNAs that encode different precursors and are processed differentially in vitro. Growth Factors 1993; 9: 205-21
27. 27. Rotwein P, Folz RJ, Gordon JI. Biosynthesis of human insulin-like growth factor-I (IGF-I). J Biol Chem 1987; 262: 11807-12
28. 28. Siegfried JM, Kasprzyk PG, Treston AM, Mulshine JL, Quinn KA, Cuttitta F. A mitogenic peptide amide encoded within the E peptide domain of the insulin-like growth factor IB prohormone. Proc Natl Acad Sci (USA) 1992; 89: 8107-11
29. 29. Quinn KA, Unsworth EJ, Miller M-J, Mulshine JL, Cuttitta F. Biochemical characterization of mouse liver IBE1-amide immunoreactivity: Limitations of antibody-based approaches for verification of peptide expression. Peptides 1996; 17: 881-3
30. 30. Hober S, Hansson A, Uhlen M, Nilsson B. Folding of insulin-like growth factor I is thermodynamically controlled by insulin-like growth factor binding protein. Biochemistry 1994; 33: 6758-61
31. 31. Helenius A, Trombetta ES, Hebert DN, Simons JF. Calnexin, calreticulin and the folding of glycoproteins. Trends in Cell Biol 1997; 7: 193-2 00
32. 32. Duguay SJ, Chan SJ, Mommsen TP, Steiner DF. Divergence of insulin-like growth factors I and II in the elasmobranch, Squalus acanthias. FEBS Lett 1995; 371: 69-72
33. 33. Powell DR, Lee PDK, Chang D, Liu F, Hintz RL. Antiserum developed for the E peptide region of insulin-like growth factor-IA prohormone recognizes a serum protein by both immunoblot and radioimmunoassay. J Clin Endocrinol Metab 1987; 65: 868-75
34. 34. Rinderknecht E, Humber RE. Primary structure of human insulin-like growth factor II. FEBS Lett 1978; 89: 283-6
35. 35. Bell GI, Merryweather JP, Sanchez-Pescador R, Stempien MM, Priestley L, Scott J, Rall LB. Sequence of a cDNA clone encoding human preproinsulin-like growth factor II. Nature 1984; 310: 775-7
36. 36. Hampton B, Burgess WH, Marshak DR, Cullen KJ, Perdue JF. Purification and characterization of an insulin-like growth factor II variant from human plasma. J Biol Chem 1989; 264: 19155-60
37. 37. Jansen M, van Schaik FMA, van Tol H, Van den Brande JL, Sussenbach JS. Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett 1985; 179: 243-6
38. 38. Dull TJ, Gray A, Hayflick JS, Ullrich A. Insulin-like growth factor II precursor gene organization in relation to insulin gene family. Nature 1984; 310: 777-81
39. 39. Lee AV, Darbre P, King RJB. Processing of insulin-like growth factor-II (IGF-II) by human breast cancer cells. Mol Cell Endocrinol 1994; 99: 211-20
40. 40. Hoeflich A, Wolf E, Braulke T, Koepf G, Kessler U, Brem G, Rascher W, Blum W, Kiess W. Does the overexpression of pro-insulin-like growth factor-II in transfected human embryonic kidney fibroblasts increase the secretion of lysosomal enzymes? Eur J Biochem 1995; 232: 172-8
41. 41. Yang CQ, Zhan X, Hu X, Kondepudi A, Perdue JF. The expression and characterization of human recombinant proinsulin-like growth factor II and a mutant that is defective in the O-glycosylation of its E domain. Endocrinology 1996; 137: 2766-73
42. 42. Yang YW-H, Romanus JA, Liu T-Y, Nissley SP, Rechler MM. Biosynthesis of insulin-like growth factor II. J Biol Chem 1985; 260: 2570-7
43. 43. Haselbacher GK, Schwab ME, Pasi A, Humbel RE. Insulin-like growth factor II (IGF-II) in human brain: Regional distribution of IGF-II and of higher molecular mass forms. Proc Natl Acad Sci (USA) 1985; 82: 2153-7
44. 44. Gowan LK, Hampton B, Hill DJ, Schlueter RJ, Perdue JF. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II. Endocrinology 1987; 121: 449-58
45. 45. Haselbacher GK, Irminger J-C, Zapf J, Ziegler WH, Humbel RE. Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: Expression at the mRNA and protein level. Proc Natl Acad Sci (USA) 1987; 84: 1104-6
46. 46. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 1988; 319: 1434-40
47. 47. Shiu RPC, Paterson JA. Characterization of insulin-like growth factor II peptides secreted by explants of neonatal brain and of adult pituitary from rats. Endocrinology 1988; 123: 1456-60
48. 48. Shapiro ET, Bell GI, Polonsky KS, Rubenstein AH, Kew MC, Tager HS. Tumor hypoglycemia: Relationship to high molecular weight insulin-like growth factor II. J Clin Invest 1990; 85: 1672-9
49. 49. Daughaday WH, Trivedi B. Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 1992; 75: 110-5
50. 50. Daughaday WH, Trivedi B. Heterogeneity of serum peptides with immunoactivity detected by a radioimmunoassay for proinsulin-like growth factor-II E-domain: Description of a free E domain peptide in serum. J Clin Endocrinol Metab 1992; 75: 641-5
51. 51. Nielsen FC, Haselbacher G, Christiansen J, Lake M, Gronborg M, Gammeltoft S. Biosynthesis of 10 kDa and 7.5 kDa insulin-like growth factor II in a human rhabdomyosarcoma cell line. Mol Cell Endocrinol 1993; 93: 87-95
52. 52. Valenzano KJ, Remmler J, Lobel P. Soluble insulin-like growth factor II/mannose 6-phosphate receptor carries multiple high molecular weight forms of insulin-like growth factor II in fetal bovine serum. J Biol Chem 1995; 270: 16441-8
53. 53. Hoog A, Sandberg-Nordqvist A-C, Abdel-Halim SM, Carlsson-Skwirut C, Guenifi A, Tally M, Ostenson C-G, Falkmer S, Sara VR, Efendic S, Schalling M, Grimelius L. Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats. Endocrinology 1996; 137: 2415-23
54. 54. Zumstein PP, Luthi C, Humbel RE. Amino acid sequence of a variant pro-form of insulin-like growth factor II. Proc Natl Acad Sci (USA) 1985; 82: 3169-72
55. 55. Hudgins WR, Hampton B, Burgess WH, Perdue JF. The identification of O-glycosylated precursors of insulin-like growth factor II. J Biol Chem 1992; 267: 8153-60
56. 56. Jespersen S, Koedam JA, Hoogerbrugge CM, Tjaden UR, van der Greef J, Van den Brande JL. Characterization of O-glycosylated precursors of insulin-like growth factor II by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrometry 1996; 31: 893-900
57. 57. Valenzano KJ, Heath-Monnig E, Tollefsen SE, Lake M, Lobel P. Biophysical and biological properties of naturally occurring high molecular weight insulin-like growth factor II variants. J Biol Chem 1997; 272: 4804-13
58. 58. Zapf J, Futo E, Peter M, Froesch ER. Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 1992; 90: 2574-84
59. 59. Daughaday WH, Trivedi B, Baxter RC. Serum "big insulin-like growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA 1993; 90: 5823-7
60. 60. Baxter RC, Daughaday WH. Impaired formation of the ternary insulin-like growth factor binding protein complex in patients with hypoglycemia due to nonislet cell tumors. J Clin Endocrinol Metab 1991; 73: 696-702
61. 61. Perdue JF, LeBon TR, Kato J, Hampton B, Fujita-Yamaguchi Y. Binding specificities and transducing function of the different molecular weight forms of insulin-like growth factor-II (IGF-II) on IGF-I receptors. Endocrinology 1991; 129: 3101-8
62. 62. Miller JA, Narhi LO, Hua CX, Rosenfeld R, Arakawa T, Rohde M, Prestrelski S, Lauren S, Stoney KS, Tsai L, Weiss MA. Oxidative refolding of insulin-like growth factor I yields two products of similar thermodynamic stability: a bifurcating protein-folding pathway. Biochemistry 1993; 18: 5203-13
63. 63. Werner H, LeRoith D. The role of the insulin-like growth factor system in human cancer. Advances in Cancer Research 1996; 68: 183-223